Imugene Limited (IMU) is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours. The Company's unique platform technologies seek to harness the body's immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies.
Find out what a historical investment in Imugene Call AUD 0.18 Imugene 30Apr27 Opt would be worth today using our IMUOF stock calculator.
Buying IMUOF shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Imugene Call AUD 0.18 Imugene 30Apr27 Opt in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in IMUOF
What is the ticker symbol of Imugene Call AUD 0.18 Imugene 30Apr27 Opt?
The ticker symbol for Imugene Call AUD 0.18 Imugene 30Apr27 Opt is IMUOF.
How much is one share of IMUOF?
One share of IMUOF is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of Imugene Call AUD 0.18 Imugene 30Apr27 Opt IMUOF?
As of 20 November 2026 Imugene Call AUD 0.18 Imugene 30Apr27 Opt has a market cap of $17.04M.
What is the 52-week high for Imugene Call AUD 0.18 Imugene 30Apr27 Opt stock?
The Imugene Call AUD 0.18 Imugene 30Apr27 Opt 52-week high stock price is $0.05.
What is the 52-week low for Imugene Call AUD 0.18 Imugene 30Apr27 Opt stock?
The Imugene Call AUD 0.18 Imugene 30Apr27 Opt 52-week low stock price is $0.00.
Can I buy IMUOF shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IMUOF shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.